FDA Inspection 764699 — Carter BloodCare, Inc.

Carter BloodCare, Inc. — FEI 1640700

The FDA completed an inspection of Carter BloodCare, Inc. on Jan 26, 2012 in Mount Pleasant, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jan 26, 2012
Fiscal Year
2012
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Mount Pleasant, TX (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.